Lv423
590 积分 2025-04-28 加入
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function
4天前
已完结
Hepatocellular carcinoma
4天前
已完结
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
4天前
已完结
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
4天前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
4天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
4天前
已完结
Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1)
5天前
已完结
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
5天前
已完结
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
7天前
已完结
Global, regional and national burden of primary liver cancer by subtype
7天前
已完结
皖公网安备34019202002308
